India Pharma Outlook Team | Friday, 20 June 2025
The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.
The showcase featured:
From mentorship to pitch visibility, the programme reflected Discovery Park’s deep commitment to nurturing high-growth startups, offering access to support systems including lab space, networks, and funding guidance.
Beyond the startup buzz, LBS 2025 delivered a robust two-day conference featuring leading voices from the Department for Science, Innovation and Technology, NHS GCC, Novo Nordisk, AWS, Microsoft, and more. Tracks spanned critical areas including AI in healthcare, regulatory challenges, and regenerative medicine.
The exhibition hosted 100+ organisations across biotech R&D, logistics, AI health tech, and advanced manufacturing. Exhibitors such as ACRO Biosystems, Merck, and Haier Biomedical drew crowds with interactive product showcases and live demos.
Meanwhile, the BioBridge London programme amplified engagement by facilitating strategic meetings between innovators and biotech buyers, driving real-world business outcomes.
Whether from a startup, investor, policymaker, or researcher’s perspective, LBS 2025 offered something for everyone—setting the stage for a stronger, more connected future in biotechnology.